Stockscreener 앱 받기
16.93
3.87%
0.63
시간 외 거래:
16.80
-0.13
-0.77%
Crescent Biopharma Inc 주식(CBIO)의 최신 뉴스
Crescent Biopharma Ord Shs (CBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Crescent Biopharma Ord Shs (CBIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Crescent Biopharma Market Sentiment - Benzinga España
Crescent Biopharma Ord Shs (CBIO) Institutional Confidence - TradingKey
CBIO|Crescent Biopharma Ord Shs|Price:16.300|Chg%:-0.730 - TradingKey
Crescent Biopharma (CBIO) Short Interest & Short Float | Updated Jul 2026 - MarketBeat
Crescent Biopharma grants inducement stock options for 52,500 shares at $15.83 each - Bitget
Crescent Biopharma Announces Grants of Inducement Awards - The Manila Times
Two Crescent Biopharma Employees Receive 52,500 Stock Options - Stock Titan
Fairmount Healthcare Fund II LP acquires 853,450 Crescent Biopharma shares for $12.38 million - Bitget
Fairmount Funds' $12 Million Bet on Crescent Biopharma: A Strong Signal Amidst Volatility - Kavout | AI
Insider fund at Crescent Biopharma (NASDAQ: CBIO) buys 1.38M shares, warrants - Stock Titan
Fairmount Funds holds 16.5% of Crescent Biopharma (CBIO) after July 2026 deal - Stock Titan
Analysts Offer Insights on Healthcare Companies: RxSight (RXST), Kazia Therapeutics (KZIA) and Crescent Biopharma (CBIO) - The Globe and Mail
Crescent Biopharma (CBIO) Jefferies Global Healthcare Conference 2026 Summary - Quartr
Crescent Biopharma closes $143.7 million public offering - Investing.com
Crescent Biopharma closes $143.7 million public offering By Investing.com - Investing.com Nigeria
Crescent Biopharma (CBIO) Proxy filing Summary - Quartr
Crescent Biopharma Announces Closing of Public Offering of - GlobeNewswire
Crescent Biopharma (CBIO) Bank of America Global Healthcare Conference 2026 Summary - Quartr
H.C. Wainwright Maintains Crescent Biopharma(CBIO.US) With Hold Rating - Moomoo
Crescent Biopharma issues pre-funded warrants for 525,897 shares in $143.7 million offering - Bitget
Form 424B5 Crescent Biopharma Inc For: 15 July By Investing.com - Investing.com Canada
Crescent Bi raises up to $133.5M in registered offering of 8.09M shares and pre-funded warrants - TradingView
Crescent Biopharma (Nasdaq: CBIO) prices $125.0 million stock and warrant sale - Stock Titan
Form 424B5 CRESCENT BIOPHARMA, INC. - StreetInsider
Crescent Biopharma (Nasdaq: CBIO) targets approximately $115.9 million raise - Stock Titan
Crescent Biopharma Prices $125 Million Common, Warrant Offering - marketscreener.com
Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants - The Manila Times
Crescent Biopharma, Inc. Files 8-K with SEC – Ordinary Shares (CBIO) Listed on NASDAQ, Key Company Details for July 2026 141649 – Minichart - Minichart
Form 424B5 Crescent Biopharma Inc For: 14 July - Investing.com UK
Crescent Biopharma launches public offering of ordinary shares By Investing.com - Investing.com Nigeria
Crescent Biopharma prices $125M public offering at $14.50/share - Investing.com
Crescent Biopharma Underwriters Have Option for Nearly 1.3M Additional Shares >CBIO - Moomoo
Crescent Biopharma prices $125M public offering of shares and pre-funded warrants - Pluang
Crescent Biopharma Expects Offering to Close July 16 >CBIO - Moomoo
Crescent Biopharma Also Offering Certain Investors Prefunded Warrants to Buy 525,897 Shares >CBIO - Moomoo
Crescent Biopharma prices $125M public offering at $14.50/share By Investing.com - Investing.com India
Crescent Biopharma Prices $125 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - Quiver Quantitative
Crescent Biopharma Sets $14.50 Price for 8.1M Shares - Stock Titan
Crescent Biopharma files for underwritten offering of ordinary shares and pre-funded warrants - MSN
Crescent Biopharma prices $125M public offering of shares - scanx.trade
Crescent Biopharma launches public offering of ordinary shares - Investing.com
Crescent Biopharma Launches Offering of Common Shares, Warrants - marketscreener.com
Form 424B5 Crescent Biopharma Inc For: 14 July By Investing.com - Investing.com India
Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants - The Manila Times
Crescent Biopharma (NASDAQ: CBIO) reports $171.6M preliminary cash as of June 30, 2026 - Stock Titan
Crescent Biopharma (NASDAQ: CBIO) details share and pre-funded warrant deal - Stock Titan
Price to earnings forward of Crescent Biopharma, Inc. – NASDAQ:CBIO - TradingView
symbol__ Stock Quote Price and Forecast - CNN
[EFFECT] CRESCENT BIOPHARMA, INC. SEC Filing - Stock Titan
Crescent Biopharma Inc (CBIO) - MSN
Crescent Biopharma (CBIO) Morgan Stanley 23rd Annual Global Healthcare Conference summary - Quartr
Enterprise value to EBITDA forward of Crescent Biopharma, Inc. – NASDAQ:CBIO - TradingView
Price to sales forward of Crescent Biopharma, Inc. – NASDAQ:CBIO - TradingView
Price to earnings forward of Crescent Biopharma, Inc. – FWB:C68 - TradingView
Price to sales forward of Crescent Biopharma, Inc. – FWB:C68 - TradingView
Enterprise value to EBIT forward of Crescent Biopharma, Inc. – NASDAQ:CBIO - TradingView
ETFs Investing in Crescent Biopharma, Inc. Stocks - TradingView
1.97%
0.83%
자본화:
|
볼륨(24시간):